Evaluation of reactive Epstein-Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS)

Brazilian Journal of Infectious Diseases

Volumn 17, Issue 2, 2013, Pages 156-163

  Ramroodi, Nourollah ^a   Niazi, Abbas Ali ^a   Sanadgol, Nima ^b,c   Ganjali, Zohre ^b   Sarabandi, Vida ^b  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ZABOL   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

EBV; ELISA; MS; QPCR; Reactivation

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME IMMUNOASSAY; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIRUS GENOME; VIRUS LOAD; VIRUS REACTIVATION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IRAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84876722721     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2012.09.008     Document Type: Article

References (45)

1. Sadovnick A.D. Genetic background of multiple sclerosis. Autoimmun Rev 2012, 11:163-166.
2. Saaroni H., Sigal A., Lejbkowicz I., Miller A. Mediterranean weather conditions and exacerbations of multiple sclerosis. Neuroepidemiology 2010, 35:142-151.
3. Disanto G., Morahan J.M., Ramagopalan S.V. Multiple sclerosis: risk factors and their interactions. CNS Neurol Disord Drug Targets 2012, 11:545-555.
4. Virtanen J.O., Jacobson S. Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets 2012, 11:528-544.
5. Brahic M. Multiple sclerosis and viruses. Ann Neurol 2010, 68:6-8.
6. Lünemann J.D. Epstein-Barr virus in multiple sclerosis: a continuing conundrum. Neurology 2012, 78:11-12.
7. Ascherio A., Munger K.L. Epstein-Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 2010, 5:271-277.
8. Tselis A. Epstein-Barr virus cause of multiple sclerosis. Curr Opin Rheumatol 2012, 24:424-428.
9. Casiraghi C., Dorovini-Zis K., Horwitz M.S. Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J Neuroimmunol 2011, 230:173-177.
10. Pender M.P. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin d deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis 2012, 189096.
11. Owens G.P., Bennett J.L. Trigger, pathogen, or bystander: the complex nexus linking Epstein-Barr virus and multiple sclerosis. Mult Scler 2012, 10.1177/1352458512448109.
12. Meier U.C., Giovannoni G., Tzartos J.S., Khan G. Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?. Clin Exp Immunol 2012, 167:1-6.
13. Pawate S., Sriram S. The role of infections in the pathogenesis and course of multiple sclerosis. Ann Indian Acad Neurol 2010, 13:80-86.
14. Chang R.A., Miller S.D., Longnecker R. Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function. Sci Rep 2012, 2:353.
15. Pender M.P. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist 2011, 17:351-367.
16. Pakpoor J., Disanto G., Gerber J.E., et al. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta- analysis. Mult Scler 2012, 10.1177/1352458512449682.
17. Santiago O., Gutierrez J., Sorlozano A., de Dios Luna J., Villegas E., Fernandez O. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis 2010, 29:857-866.
18. Polman C.H., Reingold S.C., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the " McDonald criteria.". Ann Neurol 2005, 58:840-846.
19. Sanadgol N., Ramroodi N., Ahmadi G.H.A., et al. Prevalence of cytomegalovirus infection and it role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis. New Microbiol 2011, 34:263-274.
20. Marie P. Sclerose en plaques et maladies infectieuses. Prog Med Paris 1884, 12:287-289.
21. Ontaneda D., Hyland M., Cohen J.A. Multiple sclerosis: new insights in pathogenesis and novel therapeutics. Annu Rev Med 2012, 63:389-404.
22. Krone B., Grange J.M. Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?. Autoimmune Dis 2010, 2011:708750.
23. Tselis A. Evidence for viral etiology of multiple sclerosis. Semin Neurol 2011, 31:307-316.
24. Lucas R.M., Ponsonby A.L., Dear K., et al. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011, 77:371-379.
25. Ludwin S., Jacobson S. Epstein-Barr virus and MS: causality or association?. Int MS J 2011, 17:39-43.
26. Fatima N., Toscano M.P., Hunter S.B., Cohen C. Controversial role of Epstein-Barr virus in multiple sclerosis. Appl Immunohistochem Mol Morphol 2011, 19:246-252.
27. Sargsyan S.A., Shearer A.J., Ritchie A.M., et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010, 74:1127-1135.
28. Peferoen L.A., Lamers F., Lodder L.N., et al. Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 2010, 133:e137.
29. Cohen J.I. Epstein-Barr virus infection. N Engl J Med 2000, 343:481-492.
30. Santón A., Cristóbal E., Aparicio M., Royuela A., Villar L.M., Alvarez-Cermeño J.C. High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis. Mult Scler 2011, 17:1295-1300.
31. Simon K.C., O'Reilly E.J., Munger K.L., Finerty S., Morgan A.J., Ascherio A. Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis. Mult Scler 2012, 18:1185-1187.
32. Ben Fredj N., Rotola A., Nefzi F., et al. Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors. J Neurovirol 2012, 8:12-19.
33. Khaki M., Ghazavi A., Ghasami K., et al. Evaluation of viral antibodies in Iranian multiple sclerosis patients. Neurosciences (Riyadh) 2011, 16:224-228.
34. Lerner A.M., Beqaj S.H., Gill K., Edington J., Fitzgerald J.T., Deeter R.G. An update on the management of glandular fever (infectious mononucleosis) and its sequelae caused by Epstein-Barr virus (HHV-4): new and emerging treatment strategies. Virus Adapt Treat 2010, 2:135-145.
35. Wandinger K., Jabs W., Siekhaus A., et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000, 55:178-184.
36. Villegas E., Santiago O., Carrillo J.A., et al. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients. Diagn Microbiol Infect Dis 2011, 70:85-90.
37. Giovannoni G. Epstein-Barr Virus and MS. Int MS J 2011, 17:44-49.
38. Levin L.I., Munger K.L., O'Reilly E.J., Falk K.I., Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010, 67:824-830.
39. Lindsey J.W., Hatfield L.M. Epstein-Barr virus and multiple sclerosis: cellular immune response and cross-reactivity. J Neuroimmunol 2010, 229:238-242.
40. Tzartos J.S., Khan G., Vossenkamper A., et al. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology 2012, 78:15-23.
41. Castellazzi M., Tamborino C., Cani A., et al. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis. Mult Scler 2010, 16:883-887.
42. Jaqui'ery E., Jilek S., Schluep M., et al. Intrathecal immune responses to EBV in early MS. Eur J Immunol 2010, 40:878-887.
43. Dreyfus D.H. Autoimmune disease: a role for new anti-viral therapies?. Autoimmun Rev 2011, 11:88-97.
44. Jilek S., Schluep M., Harari A., et al. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis. J Immunol 2012, 188:4671-4680.
45. Hon G.M., Hassan M.S., van Rensburg S.J., Erasmus R.T., Matsha T.E. Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis. Metab Brain Dis 2012, 27:311-318.